Oncology & Cancer

EU approves treatment for prostate cancer

The European Union has approved a new treatment against an advanced type of prostate cancer by Novartis, the Swiss pharmaceutical giant said Tuesday.

Oncology & Cancer

Study reveals pathways for aggressive prostate cancer subtype

Cribriform prostate cancer is an aggressive subtype of the disease characterized by its histology, but little is known about its molecular pathways. Research from Vanderbilt-Ingram Cancer Center has revealed new information ...

page 4 from 11